Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the REduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial-Reference-Cited by-同舟云学术

Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the REduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial

Published:2011-09 Issue:3 Volume:78 Page:641-646
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Roehrborn Claus G.,Nickel J. Curtis,Andriole Gerald L.,Gagnier R. Paul,Black Libby,Wilson Timothy H.,Rittmaster Roger S.

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. The progression of benign prostatic hyperplasia: examining the evidence and determining the risk;Anderson;Eur Urol,2001

2. Benign prostatic hyperplasia: a progressive disease of aging men;Emberton;Urology,2003

3. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia;McConnell;N Engl J Med,2003

4. The long-term outcome of medical therapy for BPH;Madersbacher;Eur Urol,2007

5. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo;Roehrborn;Urology,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term risk of benign prostatic hyperplasia‐related surgery and acute urinary retention in men treated with 5‐alpha reductase inhibitor versus alpha‐blocker monotherapy in routine clinical care;The Prostate;2023-04-14

2. Prevention of Benign Prostate Syndrome;Benign Prostate Syndrome;2023

3. Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia;Anticancer Research;2022-12-30

4. A comparison of the efficacy of dutasteride on reducing lower urinary tract symptoms among patients with small versus large benign prostatic hyperplasia;Current Urology;2022-07-28

5. Prävention des Benignen Prostatasyndroms;Benignes Prostatasyndrom;2022